<code id='D815FF1B1D'></code><style id='D815FF1B1D'></style>
    • <acronym id='D815FF1B1D'></acronym>
      <center id='D815FF1B1D'><center id='D815FF1B1D'><tfoot id='D815FF1B1D'></tfoot></center><abbr id='D815FF1B1D'><dir id='D815FF1B1D'><tfoot id='D815FF1B1D'></tfoot><noframes id='D815FF1B1D'>

    • <optgroup id='D815FF1B1D'><strike id='D815FF1B1D'><sup id='D815FF1B1D'></sup></strike><code id='D815FF1B1D'></code></optgroup>
        1. <b id='D815FF1B1D'><label id='D815FF1B1D'><select id='D815FF1B1D'><dt id='D815FF1B1D'><span id='D815FF1B1D'></span></dt></select></label></b><u id='D815FF1B1D'></u>
          <i id='D815FF1B1D'><strike id='D815FF1B1D'><tt id='D815FF1B1D'><pre id='D815FF1B1D'></pre></tt></strike></i>

          hotspot

          hotspot

          author:explore    Page View:8696
          UnitedHealth Group
          UnitedHealth Group’s Optum will pay $3.3 billion total for the home health giant Amedisys. Jim Mone/AP

          Home health and hospice chain Amedisys has chosen a new corporate owner.

          Amedisys and UnitedHealth Group’s Optum agreed to a deal Monday in which UnitedHealth will pay $101 per share in cash for Amedisys, totaling $3.3 billion. UnitedHealth’s latest offer is $1 per share higher than what it proposed in its unsolicited buyout offer a few weeks ago.

          advertisement

          Option Care Health, a company that delivers intravenous medicines and mails health care supplies to people’s homes, originally offered to acquire Amedisys in May in an all-stock deal. However, the attractiveness of that deal deteriorated after Option Care’s stock price plummeted soon after the company made its bid.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          focus

          Medicare proposal to cover medical devices draws a mixed reaction
          Medicare proposal to cover medical devices draws a mixed reaction

          AdobeThemedicaldeviceindustryissplitonwhetheraproposednewMedicarereimbursementpathwaywilldoanythingt

          read more
          The biotech scorecard for Q4: 16 stock
          The biotech scorecard for Q4: 16 stock

          RyanPierse/GettyImagesHereisSTAT’sbiotechscorecard,ourregularledgerofstock-movingbiotechevents,forth

          read more
          Activists slam private health insurers over coverage restrictions
          Activists slam private health insurers over coverage restrictions

          ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

          read more

          Medicare innovation center doesn’t save money, experts say

          AdobeWASHINGTON—AkeyObama-erainitiativewassupposedtosaveMedicaremoneybytestingnewpoliciesforcuttingh